PHIA Koninklijke Philips N.V.

Future Health Index 2024 global report: Healthcare leaders turn to AI to address critical gaps in patient care

Future Health Index 2024 global report: Healthcare leaders turn to AI to address critical gaps in patient care

June 18, 2024

  • Healthcare leaders indicate automation is crucial in addressing staff shortages, but staff remain skeptical
  • Interest in Generative AI grows, with majority of health leaders investing in, or planning to invest in AI technologies to help reduce delays in patient care

Amsterdam, the Netherlands– (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the results of its report: Better care for more people. Launched at , the ninth annual FHI global report shows that healthcare leaders are turning to virtual care and AI-enabled innovation to address pressure due to workforce shortages, financial burdens, and growing demand.

“Increasingly, we’re seeing long wait times and staff shortages making it difficult for people to get timely access to care when and where needed. The Future Health Index 2024 global findings show health leaders believe these barriers to access to quality care are getting larger,” said , Chief Innovation & Strategy Officer at Philips. “This year’s report shows how innovations including AI are helping to free up time for staff and reduce wait times for patients. However, as health systems roll out AI tools to save time and reduce barriers to care, it’s critical to bring staff along on the journey to ensure an inclusive AI rollout with patient and clinician experience is at the forefront.”

Staff shortages are taking a heavy toll on healthcare professionals and patients

Almost two-thirds (66%) of healthcare leaders report increased incidence of burnout, stress, and mental health issues in their workforce, deterioration of work-life balance, and/or reduced morale and engagement. Delays in care due to staff shortages are an issue for more than three in four healthcare leaders (77%) – causing concerns about increased waiting lists for appointments (60%), longer waiting times for treatments or procedures (57%), or delayed or limited access to screening, diagnosis, and preventive care (54%).

"The results of the FHI Report and the 3 critical gaps identified align perfectly with the challenges I face in my clinical practice each day. The staffing gap is the most concerning aspect as it has a direct negative impact on patient care. As health leaders, we need to focus on increasing the adoption of digital technologies to improve efficiency and reduce the workload, but not without engaging with healthcare staff to ensure adoption of these technologies is embraced,” said Prof. Dr. , cardiologist and CEO of the Society for Cardiovascular Magnetic Resonance (), London, UK. 

Automation can help ease the burden on staff

Most healthcare leaders (92%) agree that using technology to automate repetitive tasks or processes is critical for addressing staff shortages in healthcare. However, nearly two-thirds (65%) say healthcare professionals are skeptical about its use. Concerns were raised around automation and quality assurance and the potential for overreliance on automation leading to staff losing essential skills and knowledge. Today, automation mainly reduces the administrative burden; however, two in five (41%) healthcare leaders plan to implement it for workflow prioritization.

Virtual care may also help bridge the staffing gap, with 89% of leaders already seeing a positive impact of virtual care in easing shortages. Leaders also see benefits for staff satisfaction with more than half (54%) saying virtual care enables more flexible work schedules and creates new career options for healthcare professionals.

Patients also benefit from remote monitoring which can offer more positive experiences while reducing the strain on overstretched hospital staff. Leaders see a bigger role for remote patient monitoring in the future and are planning an expansion into areas such as telestroke care (40%), maternal and fetal health (36%), and postoperative monitoring (35%) within the next three years.

Health leaders keenly interested in Generative AI

Last year’s report showed leaders were planning investments in AI; however, the FHI 2024 results show AI for clinical decision support is already being leveraged for in-hospital patient monitoring (43%), with more investments planned in the next three years. Additionally, the majority of leaders (85%) are currently investing in, or planning to invest in, generative AI technologies.

Financial challenges must be addressed through sustainable strategies

The vast majority (81%) of leaders note that financial challenges are having a direct impact on patients. Almost 3 in 5 (59%) are unable to invest in new or more advanced medical equipment or technologies. At the same time, 89% are planning growth strategies to serve more patients or expand services. Additionally, 86% of healthcare leaders also believe that reducing CO2 emissions and the environmental impact of healthcare should be a top priority for healthcare organizations, meaning that any strategies to address financial challenges must be sustainable.

The FHI 2024 report is based on proprietary research among 3,000 healthcare leaders conducted in 14 countries. To access this year’s report, visit .

For further information, please contact:

Kathy O’Reilly

Philips Global External Relations

Tel.:

E-mail:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.

Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,100 employees with sales and services in more than 100 countries. News about Philips can be found at .

Attachments



EN
18/06/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

Marc Hesselink ... (+2)
  • Marc Hesselink
  • CFA

Philips/Execution is key/HOLD

Philips reported a better-than-expected 4Q25 update and a supportive CMD message. We increase our estimates, raise our target price from €23 to €26 and reiterate our Hold rating. Philips appears positioned to continue progressing operationally, but we believe consistent delivery will be required before we see meaningful outperformance versus the sector. Valuation at 15x adj EPS 2027F is in line with peers.

 PRESS RELEASE

Philips unveils Rembra CT at ECR 2026, setting a new benchmark for spe...

Philips unveils Rembra CT at ECR 2026, setting a new benchmark for speed and patient access designed to support diagnostic confidence for acute and high-demand imaging environments March 4, 2026 CE Marked and 510(k) pending, Rembra’s advanced image reconstruction technology delivers up to 106 images per second [1] and a high throughput of up to 270 patients per day [2] to support faster diagnosis by making scans available in near-real timeWith the largest-in-class 85 cm bore, Rembra accommodates challenging patient types, providing more access for complex interventions, bariatric imaging a...

 PRESS RELEASE

Philips publishes its Annual Report 2025

Philips publishes its Annual Report 2025 February 19, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2025. Philips’ Annual Report 2025 will be on the agenda of the Annual General Meeting of Shareholders (AGM), to be held on May 8, 2026. The convocation notice and the agenda, including explanatory notes, for the AGM will be published in due course. Philips filed the Annual Report 2025 with the Netherlands Authority for the Financial Markets (AFM) in European Single Electronic Format (ESEF) and expects to f...

 PRESS RELEASE

Philips introduces InkSpace Imaging’s Snuggle™ flexible pediatric MRI ...

Philips introduces InkSpace Imaging’s Snuggle™ flexible pediatric MRI coil for its 3.0T MR systems, helping to enhance imaging precision, efficiency and comfort February 12, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the availability of the InkSpace Imaging Snuggle™ pediatric body array coil for Philips 3.0T MRI systems. Designed specifically for pediatric patients, the Snuggle coil has been optimized and validated for use with Philips 3.0T MRI systems, bringing enhanced comfort for children and efficient, high-quality i...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

ABN Amro: Miss but strong capital, good set of results / Ahold Delhaize: Strong 4Q25 but no major surprise on FY26 adj. EPS guidance / Alfen: No recovery yet and another transitional year / BAM Group: Preview: 2026 outlook the key item / Econocom: Better REBITA, net debt, but EBIT below, much lower net profit, dividend halved, 2026-28 guidance postponed to “medium term” / Exor: Ferrari 4Q25 and 2026 guidance beat / Gecina: Results and guidance in line, DPS set to grow over 2026-30 / Heineken: No...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch